Meeting
2011 ASCO Annual Meeting
Determinants of chemotherapy administration and effects of chemotherapy on survival in elderly patients with small cell lung cancer (SCLC): A SEER-Medicare analysis.
Authors
L. C. Caprario
Holy Family Hospital, Methuen, MA
L. C. Caprario , D. M. Kent , T. A. Trikalinos , G. M. Strauss
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Local-regional and Adjuvant Therapy/Small Cell
Track
Lung Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 7083)
Abstract #
7083
Poster Bd #
29C
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Updated safety and efficacy results of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC) from a phase II trial.
First Author: Dawei Chen
Poster
2023 ASCO Genitourinary Cancers Symposium
Atezolizumab with platinum and etoposide chemotherapy followed by cystectomy for patients with localized small cell neuroendocrine bladder cancer.
First Author: Jean H. Hoffman-Censits
Poster
2023 ASCO Genitourinary Cancers Symposium
EDEN (Etude Désescalade sEmiNome): Prospective therapeutic de-escalation and miRNA-M371 biomarker evaluation phase II study for stage IIa/IIb < 3 cm seminomas.
First Author: Armelle Vinceneux
Poster
2022 ASCO Annual Meeting
Safety and efficacy of SHR-1316 combined with chemotherapy and sequential chest radiotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC): The results from a phase II single-arm trial.
First Author: Dawei Chen